CN100358509C - 采用hpmc胶囊进行肠和结肠传递 - Google Patents
采用hpmc胶囊进行肠和结肠传递 Download PDFInfo
- Publication number
- CN100358509C CN100358509C CNB998114464A CN99811446A CN100358509C CN 100358509 C CN100358509 C CN 100358509C CN B998114464 A CNB998114464 A CN B998114464A CN 99811446 A CN99811446 A CN 99811446A CN 100358509 C CN100358509 C CN 100358509C
- Authority
- CN
- China
- Prior art keywords
- coating
- medicine
- compositions
- transmits
- medicine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fertilizers (AREA)
Abstract
Description
g | 固体g | |
Eudragit L30D-55 | 1509 | 453 |
柠檬酸三乙酯 | 91 | 91 |
吐温80(33%) | 20 | 7 |
水 | 1130 | - |
g | 固体g | |
制剂4110D | 1207 | 362 |
柠檬酸三乙酯 | 18 | 18 |
单硬脂酸甘油酯 | 11 | 11 |
吐温80(33%) | 13 | 4 |
水 | 728 | - |
Claims (23)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10201798P | 1998-09-28 | 1998-09-28 | |
US60/102,017 | 1998-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1321085A CN1321085A (zh) | 2001-11-07 |
CN100358509C true CN100358509C (zh) | 2008-01-02 |
Family
ID=22287676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998114464A Expired - Fee Related CN100358509C (zh) | 1998-09-28 | 1999-09-23 | 采用hpmc胶囊进行肠和结肠传递 |
Country Status (14)
Country | Link |
---|---|
US (1) | US7094425B2 (zh) |
EP (1) | EP1117386B1 (zh) |
JP (1) | JP5068401B2 (zh) |
KR (1) | KR100695562B1 (zh) |
CN (1) | CN100358509C (zh) |
AT (1) | ATE283689T1 (zh) |
AU (1) | AU757343B2 (zh) |
CA (1) | CA2344680C (zh) |
DE (1) | DE69922394T2 (zh) |
ES (1) | ES2234306T3 (zh) |
ID (1) | ID28275A (zh) |
MX (1) | MXPA01003197A (zh) |
PT (1) | PT1117386E (zh) |
WO (1) | WO2000018377A1 (zh) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
US7115565B2 (en) | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
US7012068B2 (en) | 2001-03-27 | 2006-03-14 | Pro-Pharmaceuticals, Inc. | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
US6645946B1 (en) | 2001-03-27 | 2003-11-11 | Pro-Pharmaceuticals, Inc. | Delivery of a therapeutic agent in a formulation for reduced toxicity |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
EP1411900B2 (en) * | 2001-06-01 | 2013-12-04 | Pozen, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
EP1350507A1 (en) * | 2002-04-04 | 2003-10-08 | Applied NanoSystems B.V. | Delivery of a substance to a pre-determinated site |
DE60319822T2 (de) | 2002-06-19 | 2009-06-04 | Actogenix Nv | Verfahren und mittel zur erhöhung der darmabsorption |
US7485322B2 (en) * | 2002-12-24 | 2009-02-03 | Lek Pharmaceuticals D.D. | Modified release pharmaceutical composition |
US7737133B2 (en) | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
US7825106B2 (en) | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
ES2429095T3 (es) | 2005-05-18 | 2013-11-13 | Da Volterra | Aporte colónico de adsorbentes |
US20070082046A1 (en) * | 2005-10-11 | 2007-04-12 | Banner Pharmacaps, Inc. | Enteric valproic acid |
RU2420569C2 (ru) | 2005-11-29 | 2011-06-10 | Актогеникс Нв | Индукция толерантности к антигенам через слизистую |
PT1962873E (pt) * | 2005-12-14 | 2013-08-29 | Oxthera Inc | Composições farmacêuticas compreendendo bactérias redutoras de oxalato |
CN104013581A (zh) | 2005-12-16 | 2014-09-03 | 奥克斯赛拉公司 | 用于减少草酸和/或其盐的组合物和方法 |
US20070148248A1 (en) | 2005-12-22 | 2007-06-28 | Banner Pharmacaps, Inc. | Gastric reflux resistant dosage forms |
EP1965774A2 (en) * | 2005-12-30 | 2008-09-10 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
SE0600091L (sv) | 2006-01-18 | 2007-04-17 | Bows Pharmaceuticals Ag | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
KR20120038021A (ko) | 2006-10-27 | 2012-04-20 | 화이자 프로덕츠 인코포레이티드 | 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법 |
EP2774621B1 (en) | 2007-01-25 | 2018-01-24 | Intrexon Actobiotics NV | Treatment of immune disease by mucosal delivery of antigens |
CA2683407C (en) | 2007-04-04 | 2016-09-20 | Sigmoid Pharma Limited | Pharmaceutical cyclosporin compositions |
IT1393245B1 (it) * | 2008-07-24 | 2012-04-12 | Universita' Degli Studi Di Milano | Forme farmaceutiche per il rilascio tempo-specifico di farmaci |
US9757346B2 (en) | 2008-09-03 | 2017-09-12 | Volant Holdings Gmbh | Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes) |
WO2010027498A2 (en) * | 2008-09-03 | 2010-03-11 | New Science Holdings, Llc | Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions |
BRPI0918492A2 (pt) | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo |
KR101053731B1 (ko) * | 2008-10-21 | 2011-08-02 | 이문성 | 용해시간 조절형 장세척제 조성물의 제조방법 |
DE102009001636A1 (de) * | 2009-03-18 | 2010-09-23 | Henkel Ag & Co. Kgaa | Bleichmittel mit verzögertem Bleichbeginn |
EP2445344A4 (en) * | 2009-06-25 | 2013-01-23 | Pozen Inc | METHOD FOR THE TREATMENT OF A PATIENT REQUIRED BY ASPIRIN THERAPY |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
EP2283830A1 (en) | 2009-07-23 | 2011-02-16 | Actogenix N.V. | Aqueous enteric capsule coating |
KR101705204B1 (ko) * | 2009-09-11 | 2017-02-09 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐 |
WO2011035142A1 (en) | 2009-09-18 | 2011-03-24 | Adolor Corporation | Use of opioid receptor antagonist for gastrointestinal tract disorders |
US8765152B2 (en) | 2010-02-25 | 2014-07-01 | Evonik Roehm Gmbh | Pharmaceutical or neutraceutical formulation |
JP6027532B2 (ja) * | 2010-08-25 | 2016-11-16 | セカンド、グラント、ルーファス スパーリング | 改良された腸溶性の活性物質送達 |
JP5890428B2 (ja) | 2010-10-26 | 2016-03-22 | キャプシュゲル・ベルジウム・エヌ・ヴィ | バルク腸溶カプセルシェル |
KR101747211B1 (ko) * | 2010-11-19 | 2017-06-14 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐 |
RU2766157C2 (ru) | 2011-06-01 | 2022-02-08 | Интрексон Актобиотикс Н.В. | Система полицистронной экспрессии для бактерий |
AU2012305915B2 (en) | 2011-09-07 | 2017-09-07 | Roland Saur-Brosch | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
US20140360404A1 (en) | 2011-11-09 | 2014-12-11 | Capsugel Belgium Nv | Acid resistant banding solution for acid resistant two piece hard capsules |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
EP2830599B1 (en) | 2012-03-29 | 2018-08-15 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
CN103355656B (zh) * | 2012-04-01 | 2016-01-20 | 中国科学院大连化学物理研究所 | 一种益生菌微胶囊产品及其制备与应用 |
CA2870134C (en) | 2012-05-02 | 2020-04-28 | Capsugel France SAS | Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
CN104661655A (zh) * | 2012-07-23 | 2015-05-27 | 陶氏环球技术有限责任公司 | 用于硬质胶囊外壳的膜组合物 |
US20140066837A1 (en) | 2012-07-26 | 2014-03-06 | Ronald L. Moy | Skin care compositions and methods |
EP2890367A4 (en) * | 2012-08-29 | 2016-03-30 | Salix Pharmaceuticals Inc | REMEDY COMPOSITION AND METHOD FOR TREATING CONSTELLATION AND RELATED DISEASES AND SUFFERING THE STOMACH DARM TRAKT |
US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
WO2014120804A1 (en) * | 2013-01-30 | 2014-08-07 | University Of Miami | Enteric coated nanoparticles for oral vaccine and drug delivery and methods of production and use thereof |
CN105120847B (zh) | 2013-03-14 | 2018-12-28 | 塞拉拜姆有限责任公司 | 益生生物和/或治疗剂的靶向胃肠道递送 |
US20160256399A1 (en) | 2013-11-04 | 2016-09-08 | Capsugel Belgium Nv | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
DK2946774T3 (da) * | 2014-05-19 | 2020-05-25 | Tillotts Pharma Ag | Coatede kapsler med modificeret frigivelse |
EP3028694B1 (en) | 2014-12-02 | 2017-07-12 | Capsugel Belgium NV | Dosage form articles for delayed release |
EP3167880B1 (en) | 2015-11-10 | 2019-06-19 | Capsugel Belgium NV | Acid resistant banding or sealing solution for acid resistant two piece hard capsules |
CN108883140A (zh) | 2016-01-14 | 2018-11-23 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 治疗1型糖尿病的组合物和方法 |
CN109563176B (zh) * | 2016-08-23 | 2021-09-28 | 陶氏环球技术有限责任公司 | 邻苯二甲酸乙酸纤维素醚 |
CA3035151A1 (en) | 2016-09-02 | 2018-03-08 | Intrexon Actobiotics N.V. | Genetically modified bacteria stably expressing il-10 and insulin |
CN109983028B (zh) | 2016-09-13 | 2023-10-20 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 黏膜黏附性微生物 |
US10561630B2 (en) | 2016-10-25 | 2020-02-18 | Glykon Technologies Group, Llc | Hydroxycitric acid compounds and capsule liquid delivery |
BR112020000011A2 (pt) | 2017-07-11 | 2020-07-21 | Qualicaps Co., Ltd. | cápsula dura entérica |
US20210113479A1 (en) * | 2018-05-03 | 2021-04-22 | M.W. Encap Limited | Dosage forms for delivery of medicines to the lower gastrointestinal tract |
CA3104459A1 (en) | 2018-06-22 | 2019-12-26 | Qualicaps Co., Ltd. | Enteric hard capsule |
EP3610862A1 (en) * | 2018-08-14 | 2020-02-19 | Apillet APS | Novel oral composition |
CN109528689B (zh) * | 2018-12-24 | 2021-09-21 | 江苏辰星药业股份有限公司 | 一种肠溶缓释植物胶囊及其制备方法 |
AU2020356592A1 (en) | 2019-09-27 | 2022-04-07 | Intrexon Actobiotics Nv D/B/A Precigen Actobio | Treatment of celiac disease |
WO2022016397A1 (zh) * | 2020-07-22 | 2022-01-27 | 绍兴康可胶囊有限公司 | 羟丙甲纤维素空心胶囊 |
CN113164404B (zh) * | 2020-07-22 | 2022-09-02 | 绍兴康可胶囊有限公司 | 肠溶羟丙甲纤维素空心胶囊 |
WO2022137265A1 (en) * | 2021-10-18 | 2022-06-30 | Nutra Grace | Enteric coated hpmc based herbal oil capsule for treatment of irritable bowel syndrome |
WO2023212749A2 (en) * | 2022-04-29 | 2023-11-02 | Novatek Therapeutics, Llc | Black seed oil formulations |
WO2024117395A1 (ko) * | 2022-11-30 | 2024-06-06 | 주식회사 마이크로바이오틱스 | 대변 미생물총 이식용 이중캡슐 및 이의 제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995035100A1 (en) * | 1994-06-21 | 1995-12-28 | Danbiosyst Uk Limited | Colonic drug delivery composition |
EP0754452A2 (en) * | 1995-07-20 | 1997-01-22 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
US5705189A (en) * | 1994-08-31 | 1998-01-06 | Roehm Gmbh Chemische Fabrik | Thermoplastic material for drug coatings which dissolve in intestinal juices |
WO1998005310A1 (fr) * | 1996-08-02 | 1998-02-12 | Hisamitsu Pharmaceutical Co., Inc. | Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4138013A (en) | 1976-08-27 | 1979-02-06 | Parke, Davis & Company | Enteric capsules |
JPS61100519A (ja) * | 1984-10-23 | 1986-05-19 | Shin Etsu Chem Co Ltd | 医薬用硬質カプセル |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
JP3116602B2 (ja) * | 1992-10-06 | 2000-12-11 | シオノギクオリカプス株式会社 | 硬質カプセル |
US5656290A (en) * | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
DE4329503A1 (de) * | 1993-09-01 | 1995-03-02 | Galenik Labor Freiburg Gmbh | Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa |
JP2959423B2 (ja) * | 1994-12-01 | 1999-10-06 | シオノギクオリカプス株式会社 | カプセル用皮膜組成物 |
JP3185206B2 (ja) * | 1995-07-20 | 2001-07-09 | 田辺製薬株式会社 | 消化管下部放出型被覆カプセル製剤 |
JPH10152431A (ja) * | 1996-08-02 | 1998-06-09 | Hisamitsu Pharmaceut Co Inc | 経口製剤用カプセルと経口カプセル製剤 |
-
1999
- 1999-09-23 JP JP2000571897A patent/JP5068401B2/ja not_active Expired - Fee Related
- 1999-09-23 CA CA002344680A patent/CA2344680C/en not_active Expired - Fee Related
- 1999-09-23 MX MXPA01003197A patent/MXPA01003197A/es not_active IP Right Cessation
- 1999-09-23 ID IDW20010705A patent/ID28275A/id unknown
- 1999-09-23 AT AT99949822T patent/ATE283689T1/de active
- 1999-09-23 WO PCT/US1999/022117 patent/WO2000018377A1/en active IP Right Grant
- 1999-09-23 KR KR1020017003897A patent/KR100695562B1/ko not_active IP Right Cessation
- 1999-09-23 ES ES99949822T patent/ES2234306T3/es not_active Expired - Lifetime
- 1999-09-23 EP EP99949822A patent/EP1117386B1/en not_active Expired - Lifetime
- 1999-09-23 DE DE69922394T patent/DE69922394T2/de not_active Expired - Lifetime
- 1999-09-23 CN CNB998114464A patent/CN100358509C/zh not_active Expired - Fee Related
- 1999-09-23 AU AU62613/99A patent/AU757343B2/en not_active Ceased
- 1999-09-23 PT PT99949822T patent/PT1117386E/pt unknown
-
2001
- 2001-04-17 US US09/836,627 patent/US7094425B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995035100A1 (en) * | 1994-06-21 | 1995-12-28 | Danbiosyst Uk Limited | Colonic drug delivery composition |
US5705189A (en) * | 1994-08-31 | 1998-01-06 | Roehm Gmbh Chemische Fabrik | Thermoplastic material for drug coatings which dissolve in intestinal juices |
EP0754452A2 (en) * | 1995-07-20 | 1997-01-22 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
WO1998005310A1 (fr) * | 1996-08-02 | 1998-02-12 | Hisamitsu Pharmaceutical Co., Inc. | Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale |
Also Published As
Publication number | Publication date |
---|---|
US20010036473A1 (en) | 2001-11-01 |
AU6261399A (en) | 2000-04-17 |
ES2234306T3 (es) | 2005-06-16 |
CA2344680C (en) | 2008-11-25 |
KR100695562B1 (ko) | 2007-03-15 |
ATE283689T1 (de) | 2004-12-15 |
KR20010075395A (ko) | 2001-08-09 |
MXPA01003197A (es) | 2004-04-21 |
EP1117386A1 (en) | 2001-07-25 |
CN1321085A (zh) | 2001-11-07 |
JP2002525314A (ja) | 2002-08-13 |
PT1117386E (pt) | 2005-04-29 |
AU757343B2 (en) | 2003-02-20 |
WO2000018377A1 (en) | 2000-04-06 |
JP5068401B2 (ja) | 2012-11-07 |
DE69922394D1 (de) | 2005-01-05 |
US7094425B2 (en) | 2006-08-22 |
EP1117386B1 (en) | 2004-12-01 |
ID28275A (id) | 2001-05-10 |
DE69922394T2 (de) | 2005-12-22 |
CA2344680A1 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100358509C (zh) | 采用hpmc胶囊进行肠和结肠传递 | |
US6228396B1 (en) | Colonic drug delivery composition | |
JPH0441422A (ja) | 大腸崩壊性硬質カプセル | |
AU2005334837B2 (en) | PH-controlled pulsatile delivery system, methods for preparation and use thereof | |
US7485294B2 (en) | Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof | |
JPH04501411A (ja) | 結腸選択的到達性を持つ経口医薬用製剤 | |
Cheng et al. | Design and application of oral colon administration system | |
US20240082168A1 (en) | Controlled drug release formulation | |
CN104257669A (zh) | 一种用于向肠道递送水杨酸类药物的口服给药组合物 | |
EP2046306B1 (en) | Coating composition comprising starch | |
CA3122025A1 (en) | Colonic drug delivery formulation | |
WO2017156214A1 (en) | Pharmaceutical compositions for colon-specific delivery | |
Raghuvanshi et al. | Various approaches for targeting colon: a review | |
Raghuvanshi et al. | Journal of Applied Pharmaceutical Research ISSN No. 2348–0335 www. japtronline. com |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CAPSUGEL BELGIUM BVBA Free format text: FORMER OWNER: WARNER-LAMBERT CO. Effective date: 20121130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: WARNER-LAMBERT CO. Free format text: FORMER NAME: WARNER-LAMBERT COMPANY Owner name: CAPSUGEL BELGIUM NV Free format text: FORMER NAME: CAPSUGEL BELGIUM BVBA |
|
CP01 | Change in the name or title of a patent holder |
Address after: Belgian rum Patentee after: Capsugel Belgium N.V. Address before: Belgian rum Patentee before: Belgium capsule Co.,Ltd. Address after: New jersey, USA Patentee after: WARNER-LAMBERT CO.,LLC Address before: New jersey, USA Patentee before: WARNER-LAMBERT Co.,LLC |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121130 Address after: Belgian rum Patentee after: Belgium capsule Co.,Ltd. Address before: New jersey, USA Patentee before: WARNER-LAMBERT CO.,LLC |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080102 Termination date: 20150923 |
|
EXPY | Termination of patent right or utility model |